Your shopping cart is empty!
Clinical and Laboratory Standards Institute, 12/01/1999
Publisher: CLSI
File Format: PDF
$124.00$249.27
Published:01/12/1999
Pages:70
CLSI MM04-A provides recommendations for the performance of immunocytochemical assays on cytologic and surgical pathology specimens. It is intended to promote a better understanding of the requirements, capabilities, and limitations of these diagnostic methods; to improve their intra- and inter-laboratory reproducibility; and to improve their positive and negative predictive values in the diagnosis of disease.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
Antiviral Susceptibility Testing: Herpes Simplex Virus by Plaque Reduction Assay; Approved Standard, M33AE
$120.00 $240.30
Quality Control of Microbiological Transport Systems; Approved Standard, M40A
$142.00 $285.39
Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard, M11-A6
$141.00 $283.22
Methods for Reticulocyte Counting (Flow Cytometry and Supravital Dyes); Approved Guideline, H44-A2
$134.00 $269.27